Edwards Lifesciences Corp banner

Wall St Price Targets

EW Price Forecast
Based on 32 analysts

-17% Downside
from Mex$2 348.71 today

Edwards Lifesciences Corp (EW)’s 12-month stock price forecast through October 2027 has a consensus target of Mex$1 958.25, implying 17% downside. The forecast is based on price targets from 32 Wall Street analysts.

EW Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for EW yet.

Edwards Lifesciences Corp Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is EW's stock price target?
Price Target
1 958.25 MXN

According to Wall Street analysts, the average 1-year price target for EW is 1 958.25 MXN with a low forecast of 1 640 MXN and a high forecast of 2 346.81 MXN.

What is the Revenue forecast for Edwards Lifesciences Corp?
Projected CAGR
10%

Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 5 years is 10%.

What is the Gross Profit forecast for Edwards Lifesciences Corp?
Projected CAGR
10%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 5 years is 10%.

What is the Operating Income forecast for Edwards Lifesciences Corp?
Projected CAGR
13%

Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 5 years is 13%.

What is the Pre-Tax Income forecast for Edwards Lifesciences Corp?
Projected CAGR
28%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 28%.

What is the Net Income forecast for Edwards Lifesciences Corp?
Projected CAGR
20%

Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 5 years is 20%.

Back to Top